V.H. + H-120 - atenuowany wirus rzekomego pomoru ptaków (choroby Newcastle), szczep VHnie mniej niż 10^6,0 EID50 i nie więcej niż 10^7,49 EID50;- atenuowany wirus zakaźnego zapalenia oskrzeli ptaków, szczep H-120nie mniej niż 10^3,5 EID50 i nie więcej niż 10^4,49 EID50. Liofilizat do sporządzania zawiesiny
V.H. + H-120 - atenuowany wirus rzekomego pomoru ptaków (choroby Newcastle), szczep VHnie mniej niż 10^6,0 EID50 i nie więcej niż 10^7,49 EID50;- atenuowany wirus zakaźnego zapalenia oskrzeli ptaków, szczep H-120nie mniej niż 10^3,5 EID50 i nie więcej niż 10^4,49 EID50. Liofilizat do sporządzania zawiesiny
Authorised
- Newcastle disease virus, strain V.H., Live
- Avian infectious bronchitis virus, type Massachusetts, strain H120, Live
Product identification
Medicine name:
V.H. + H-120 - atenuowany wirus rzekomego pomoru ptaków (choroby Newcastle), szczep VHnie mniej niż 10^6,0 EID50 i nie więcej niż 10^7,49 EID50;- atenuowany wirus zakaźnego zapalenia oskrzeli ptaków, szczep H-120nie mniej niż 10^3,5 EID50 i nie więcej niż 10^4,49 EID50. Liofilizat do sporządzania zawiesiny
Active substance:
- Newcastle disease virus, strain V.H., Live
- Avian infectious bronchitis virus, type Massachusetts, strain H120, Live
Target species:
-
Chicken (hen)
Route of administration:
-
Nebulisation use
-
In drinking water use
Product details
Active substance and strength:
-
Newcastle disease virus, strain V.H., Live30903000.00/50% Embryo Infective Dose1.0050% Embryo Infective Dose
-
Avian infectious bronchitis virus, type Massachusetts, strain H120, Live30903.00/50% Embryo Infective Dose1.0050% Embryo Infective Dose
Pharmaceutical form:
-
Lyophilisate for suspension
Withdrawal period by route of administration:
-
Nebulisation use
-
Chicken (hen)
-
All relevant tissues0day
-
-
-
In drinking water use
-
Chicken (hen)
-
All relevant tissues0day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI01AD06
- QI01AD07
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Poland
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Well-established use application (Article 13a of Directive No 2001/82/EC)
Marketing authorisation holder:
- Phibro Animal Health (Poland) Sp. z o.o.
Marketing authorisation date:
Manufacturing sites for batch release:
- Synoptis Industrial Sp. z o.o.
Responsible authority:
- Office For Registration Of Medicinal Products Medical Devices And Biocidal Products
Authorisation number:
- 1232
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Polish (PDF)
Published on: 13/08/2024
Labelling
This document does not exist in this language (English). You can find it
in another language below.
Polish (PDF)
Published on: 13/08/2024
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Polish (PDF)
Published on: 13/08/2024
How useful was this page?:
